GLP Watchdog

Noom vs Remedy Meds

Remedy Meds has an open FDA warning letter dated September 9, 2025. Noom has none. On compounded semaglutide injection, Noom costs $1,440 less a year at standing rates: $179 a month against $299 a month at Remedy Meds.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Noom / Remedy Meds

Noom logo

Noom

5.8/10

Remedy Meds logo

Remedy Meds

5.6/10

FDA warning letters
None on record
Pharmacy
None named in our record
None named in our record
Lowest standing price
$179/moCompounded semaglutide injection
$299/moCompounded semaglutide injection
States
No state list published
49 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit Noom
Visit Remedy Meds

Neither Noom nor Remedy Meds pays us. Links to them earn nothing. Scores: Noom 5.8, Remedy Meds 5.6. How we are paid

What the record shows

  1. 01

    Remedy Meds has an open FDA warning letter dated September 9, 2025. Noom has none.

  2. 02

    Neither names the pharmacy that compounds its medication.

  3. 03

    On compounded semaglutide injection, Noom costs $1,440 less a year at standing rates: $179 a month against $299 a month at Remedy Meds.

  4. 04

    Only Noom lists a price for brand-name tirzepatide pen. Only Remedy Meds lists a price for compounded tirzepatide injection.

  5. 05

    Remedy Meds lists 49 states. Noom publishes no state list.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Noom

Remedy Meds

Compounded semaglutide injection

$179/moLower

$2,148 a year

$299/mo

$3,588 a year

Compounded tirzepatide injection
Not sold or not priced

$399/mo

$4,788 a year

Brand-name tirzepatide pen

$349/mo

$4,188 a year

Not sold or not priced
Price includes
Clinician visits, coaching
Medication, clinician visits, shipping
Cancel any time
Yes, stated
Yes, stated
Minimum term
Not stated
None
Refunds
Refunds only before a prescription is written; renewal charges are not refunded
No refund once a payment is processed; full refund of the first payment if found ineligible; 12-month weight-loss warranty on program fees

Read off each seller’s own pages. Noom: October 30, 2026. Remedy Meds: October 30, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Noom

5.8/10
  • No FDA warning letter on record
  • $1,440 a year less on compounded semaglutide injection
  • Sells brand-name tirzepatide pen, which Remedy Meds does not price
  • Names no compounding pharmacy
  • Publishes no state list
Visit Noom

The case for Remedy Meds

5.6/10
  • Sells compounded tirzepatide injection, which Noom does not price
  • Open FDA warning letter, September 9, 2025
  • Names no compounding pharmacy
Visit Remedy Meds

Scores

Noom 5.8 · Remedy Meds 5.6 out of 10. Six weighted parts.

Value25%

0.9A
vs
B
3.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
2.5

Trust & Safety15%

6.5A
vs
B
2.0

Accessibility10%

5.0A
vs
B
9.8

Support10%

4.0A
vs
B
7.0

The score is the same formula for every seller. Payment does not enter it. Method

Noom vs Remedy Meds: questions

Remedy Meds has an open FDA warning letter dated September 9, 2025. Noom has none. Letters are matched to a seller by company, domain and address, never by a similar name.
Neither names the pharmacy that compounds its medication.
Noom, by $1,440 a year at standing rates. Noom: $179 a month, about $2,148 a year. Remedy Meds: $299 a month, about $3,588 a year.
Noom states you can cancel at any time; refunds: refunds only before a prescription is written; renewal charges are not refunded. Remedy Meds states you can cancel at any time; refunds: no refund once a payment is processed; full refund of the first payment if found ineligible; 12-month weight-loss warranty on program fees.
Neither Noom nor Remedy Meds pays us. Links to them earn nothing. Scores: Noom 5.8, Remedy Meds 5.6.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks